logging in or signing up Prin of ID pattersonby Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 299 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: November 19, 2008 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Introduction to Infectious Diseases: Introduction to Infectious Diseases 1 Brooke Y. Patterson, PharmD, BCPS NU 7080: Advanced Pharmacology Research College of NursingInfectious Diseases Are Everywhere!: Infectious Diseases Are Everywhere! Influenza: 3-5 million infected annually HIV/AIDS: 45 million infected Hepatitis C: 170 million infected annually Malaria: 300 million new infections annually Hepatitis B: 2 billion infected Tuberculosis: 2-3 billion infected 2Biology of Infectious Diseases: Biology of Infectious Diseases Microbial invasion Virulence factors Microbial adherence Microbial resistance Host defense mechanisms Natural barriers Non-specific immune responses Specific immune response 3Microbial Invasion: Microbial Invasion Virulence factors Encapsulation Enzymatic activity Exotoxins Impairment of antibody production Phagocytosis resistance 4Microbial Invasion: Microbial Invasion Microbial adherence Adhesins Biofilm Antimicrobial resistance Selection of resistant strains Drug 'pressure' 5Host Defense Mechanisms: Host Defense Mechanisms Natural Barriers Skin Mucous membrane secretions Airway filters GI tract pH Non-specific Immune Responses Fever Increased production of neutrophils Inflammatory response 6Host Defense Mechanisms: Host Defense Mechanisms Specific Immune Responses Antibodies Complement system 7Principles of Treatment: Principles of Treatment How We Treat An Infection 8Principles of Treatment: Principles of Treatment 9Recognize Patient’s Illness: Recognize Patient’s Illness Fever Oral temp >99.5-100.5°F (37.5-38°C) Hallmark of infection Non-infectious causes Malignancy Drug fever Blood transfusions Absence in presence of suspected infection Antipyretics Corticosteroids Antimicrobial therapy Overwhelming infection (sepsis) 10Recognize Patient’s Illness: Recognize Patient’s Illness White blood cell (WBC) count Increased (leukocytosis) Normal range: 4000-10,000 cells/mm3 11Recognize Patient’s Illness: Recognize Patient’s Illness WBC Differential Mature neutrophils 50-70% Immature neutrophils ('bands') 3-5% Lymphocytes 20-40% Monocytes 0-7% Eosinophils 0-5% Bacterial infections Increased neutrophils ('left shift') Viral infections Increased lymphocytes (lymphocytosis) Allergic reactions and/or protozoal infection Increased eosinophils (eosinophilia) 12Recognize Patient’s Illness: Recognize Patient’s Illness Pain and inflammation Symptoms referable to specific organ system 13Recognizing Patient’s Illness: Recognizing Patient’s Illness Factors predisposing to illness Alterations in normal flora of host Disruption of natural barriers Skin/mucous membrane Cilia of respiratory tract pH and motility of bowel Age Immunosuppression 14Principles of Treatment: Principles of Treatment 15Identify Causative Organism: Identify Causative Organism Aerobic microorganisms Gram-positive cocci Gram-positive bacilli Gram-negative cocci Gram-negative bacilli Enterobacteriaceae family Anaerobic microorganisms Gram-positive cocci Gram-positive bacilli Gram-negative bacilli 16Identify Causative Organism: Identify Causative Organism Our bodies are covered in bacteria! Normal flora Skin Staphylococci sp. Streptococci sp. Upper Respiratory Tract Haemophilus sp Streptococci (viridans group) Oral anaerobes 17Identify Causative Organism: Identify Causative Organism Gastrointestinal Tract Bacteriodes sp. Enterobacteriaceae Enterococci Fusobacterium sp. Peptostreptococci Genital Tract Enterobacteriaceae Corynebacterium sp. Lactobacillus sp. Mycoplasma sp. Staphylococci Streptococci 18Identify Causative Organism: Identify Causative Organism Collect infected material Aspiration of infected fluids Direct examination of fluids Gram stain AFB stain India ink Immunologic examination of fluids ELISA DNA probes Cultures 19Identify Causative Organism: Identify Causative Organism Collect fluids Blood Sputum Urine LP Multiple specimens taken Error possiblecontamination 20Principles of Treatment: Principles of Treatment 21Choose Antimicrobial Therapy: Choose Antimicrobial Therapy Empiric vs. directed antimicrobial therapy Microorganisms most likely to cause infection Antimicrobial susceptibility pattern Selecting antibiotic Efficacy Microbiologic efficacy Susceptibility tests Resistance trends Pharmacokinetics 22Choose Antimicrobial Therapy: Choose Antimicrobial Therapy Susceptibility testing Based on MIC Broth dilution, agar dilution, E-test Lowest concentration resulting in >99% decrease in organism Reported in 3 different categories Susceptible Intermediate Resistant 23Choose Antimicrobial Therapy: Choose Antimicrobial Therapy 24Choose Antimicrobial Therapy: Choose Antimicrobial Therapy 'The tissue is the issue' Distribution Serum concentrations Host factors to consider when choosing an agent Allergy or h/o ADRs Age and weight Pregnancy Genetic or metabolic abnormalities (pharmacodynamics) Renal and hepatic function Concomitant drug therapy Underlying disease states 25Principles of Treatment: Principles of Treatment 26Monitor For Improvement: Monitor For Improvement Clinical assessment Physical exam Radiographic evidence Laboratory tests Cultures Therapeutic drug monitoring 27Monitor For Improvement: Monitor For Improvement Assessment of Clinical Failures Antimicrobial selection Host factors Microorganism factors Laboratory errors 28Antimicrobial Resistance: Antimicrobial Resistance Why Some Bacteria Are Hard To Treat 29Antimicrobial Resistance: Antimicrobial Resistance Intrinsic resistance Acquired resistance Mutation Genetic exchange Acquisition of new DNA 30Susceptibility Testing: Susceptibility Testing Determine if microorganism is susceptible to drug Guides therapy 31Susceptibility Testing: Susceptibility Testing Minimum Inhibitory Concentration (MIC) Lowest concentration that prevents visible growth Broth dilution NCCLS 'breakpoints' used to categorize MIC Susceptible Intermediate Resistant 32Susceptibility Testing: Susceptibility Testing Disc Diffusion (Kirby-Bauer) Antibiotic-impregnated disk is placed on agar plate of growing organism Zone created by antibiotic leaching from the disk into the agar is compared to NCCLS ranges 33Pathogenic Bacteria: Pathogenic Bacteria What Makes Us Sick 34Gram-Positive Bacteria: Gram-Positive Bacteria Marked increase in antibiotic resistance Serious and difficult-to-treat infections 35Staphylococci: Staphylococci Staphylococcus aureus Remarkable amount of disease manifestations MRSA Bacteremia and TSS possible Staphylococcus epidermidis Coagulase-negative staph Staphylococcus saprophyticus 36Staphyloccocus aureus: Staphyloccocus aureus 37Staphylococcus Epidermidis: Staphylococcus Epidermidis 38Staphylococcus Saprophyticus: Staphylococcus Saprophyticus 39Pneumoccoci: Pneumoccoci Streptococcus pneumoniae Forcefully attack human body Cause significant amounts of tissue damage Associated with extensive inflammatory response 40Streptococcus pneumoniae: Streptococcus pneumoniae 41Enterococci: Enterococci 'Fickle' residents of the human GI tract Enterococcus faecalis Enterococcus faecium 42Enterococci: Enterococci 43Gram-Negative Bacteria: Gram-Negative Bacteria Most common cause of infection in humans Enterobacteriaceae Large family of bacteria responsible for GI, urinary and opportunistic infections Enteric gram-negative rods 44Enterobacteriaceae: Enterobacteriaceae Escherichia coli Klebsiella spp Proteus spp Enterobacter spp Serratia spp Citrobacter spp Providenicia spp Morganella spp Salmonella enterica Shigella spp Yersinia spp 45Enterobacteriaceae: Enterobacteriaceae 46Pseudomonas: Pseudomonas Pseudomonas aeruginosa Frequent cause of hospital-acquired infections Harbors an array of resistance mechanisms 47Pseudomonas Aeruginosa: Pseudomonas Aeruginosa 48Neisseria: Neisseria Neisseria meningitidis Meningitis Bacteremia possible Neisseria gonorrhoeae Genital gonorrhea 49Anaerobic Bacteria: Anaerobic Bacteria Bacteria unable to grow in the presence of physiologic concentrations of oxygen Mucosal surfaces 50Clostridia: Clostridia Gram-positive spore-forming anaerobic bacteria Clostridium difficile Clostridium tetani 51Clostridia spp: Clostridia spp 52Questions???: Questions??? 53Clostridia spp: Clostridia spp 52Questions???: Questions??? 53 You do not have the permission to view this presentation. In order to view it, please contact the author of the presentation.
Prin of ID pattersonby Download Post to : URL : Related Presentations : Share Add to Flag Embed Email Send to Blogs and Networks Add to Channel Uploaded from authorPOINT Insert YouTube videos in PowerPont slides with aS Desktop Copy embed code: (To copy code, click on the text box) Embed: URL: Thumbnail: WordPress Embed Customize Embed The presentation is successfully added In Your Favorites. Views: 299 Category: Education License: All Rights Reserved Like it (0) Dislike it (0) Added: November 19, 2008 This Presentation is Public Favorites: 0 Presentation Description No description available. Comments Posting comment... Premium member Presentation Transcript Introduction to Infectious Diseases: Introduction to Infectious Diseases 1 Brooke Y. Patterson, PharmD, BCPS NU 7080: Advanced Pharmacology Research College of NursingInfectious Diseases Are Everywhere!: Infectious Diseases Are Everywhere! Influenza: 3-5 million infected annually HIV/AIDS: 45 million infected Hepatitis C: 170 million infected annually Malaria: 300 million new infections annually Hepatitis B: 2 billion infected Tuberculosis: 2-3 billion infected 2Biology of Infectious Diseases: Biology of Infectious Diseases Microbial invasion Virulence factors Microbial adherence Microbial resistance Host defense mechanisms Natural barriers Non-specific immune responses Specific immune response 3Microbial Invasion: Microbial Invasion Virulence factors Encapsulation Enzymatic activity Exotoxins Impairment of antibody production Phagocytosis resistance 4Microbial Invasion: Microbial Invasion Microbial adherence Adhesins Biofilm Antimicrobial resistance Selection of resistant strains Drug 'pressure' 5Host Defense Mechanisms: Host Defense Mechanisms Natural Barriers Skin Mucous membrane secretions Airway filters GI tract pH Non-specific Immune Responses Fever Increased production of neutrophils Inflammatory response 6Host Defense Mechanisms: Host Defense Mechanisms Specific Immune Responses Antibodies Complement system 7Principles of Treatment: Principles of Treatment How We Treat An Infection 8Principles of Treatment: Principles of Treatment 9Recognize Patient’s Illness: Recognize Patient’s Illness Fever Oral temp >99.5-100.5°F (37.5-38°C) Hallmark of infection Non-infectious causes Malignancy Drug fever Blood transfusions Absence in presence of suspected infection Antipyretics Corticosteroids Antimicrobial therapy Overwhelming infection (sepsis) 10Recognize Patient’s Illness: Recognize Patient’s Illness White blood cell (WBC) count Increased (leukocytosis) Normal range: 4000-10,000 cells/mm3 11Recognize Patient’s Illness: Recognize Patient’s Illness WBC Differential Mature neutrophils 50-70% Immature neutrophils ('bands') 3-5% Lymphocytes 20-40% Monocytes 0-7% Eosinophils 0-5% Bacterial infections Increased neutrophils ('left shift') Viral infections Increased lymphocytes (lymphocytosis) Allergic reactions and/or protozoal infection Increased eosinophils (eosinophilia) 12Recognize Patient’s Illness: Recognize Patient’s Illness Pain and inflammation Symptoms referable to specific organ system 13Recognizing Patient’s Illness: Recognizing Patient’s Illness Factors predisposing to illness Alterations in normal flora of host Disruption of natural barriers Skin/mucous membrane Cilia of respiratory tract pH and motility of bowel Age Immunosuppression 14Principles of Treatment: Principles of Treatment 15Identify Causative Organism: Identify Causative Organism Aerobic microorganisms Gram-positive cocci Gram-positive bacilli Gram-negative cocci Gram-negative bacilli Enterobacteriaceae family Anaerobic microorganisms Gram-positive cocci Gram-positive bacilli Gram-negative bacilli 16Identify Causative Organism: Identify Causative Organism Our bodies are covered in bacteria! Normal flora Skin Staphylococci sp. Streptococci sp. Upper Respiratory Tract Haemophilus sp Streptococci (viridans group) Oral anaerobes 17Identify Causative Organism: Identify Causative Organism Gastrointestinal Tract Bacteriodes sp. Enterobacteriaceae Enterococci Fusobacterium sp. Peptostreptococci Genital Tract Enterobacteriaceae Corynebacterium sp. Lactobacillus sp. Mycoplasma sp. Staphylococci Streptococci 18Identify Causative Organism: Identify Causative Organism Collect infected material Aspiration of infected fluids Direct examination of fluids Gram stain AFB stain India ink Immunologic examination of fluids ELISA DNA probes Cultures 19Identify Causative Organism: Identify Causative Organism Collect fluids Blood Sputum Urine LP Multiple specimens taken Error possiblecontamination 20Principles of Treatment: Principles of Treatment 21Choose Antimicrobial Therapy: Choose Antimicrobial Therapy Empiric vs. directed antimicrobial therapy Microorganisms most likely to cause infection Antimicrobial susceptibility pattern Selecting antibiotic Efficacy Microbiologic efficacy Susceptibility tests Resistance trends Pharmacokinetics 22Choose Antimicrobial Therapy: Choose Antimicrobial Therapy Susceptibility testing Based on MIC Broth dilution, agar dilution, E-test Lowest concentration resulting in >99% decrease in organism Reported in 3 different categories Susceptible Intermediate Resistant 23Choose Antimicrobial Therapy: Choose Antimicrobial Therapy 24Choose Antimicrobial Therapy: Choose Antimicrobial Therapy 'The tissue is the issue' Distribution Serum concentrations Host factors to consider when choosing an agent Allergy or h/o ADRs Age and weight Pregnancy Genetic or metabolic abnormalities (pharmacodynamics) Renal and hepatic function Concomitant drug therapy Underlying disease states 25Principles of Treatment: Principles of Treatment 26Monitor For Improvement: Monitor For Improvement Clinical assessment Physical exam Radiographic evidence Laboratory tests Cultures Therapeutic drug monitoring 27Monitor For Improvement: Monitor For Improvement Assessment of Clinical Failures Antimicrobial selection Host factors Microorganism factors Laboratory errors 28Antimicrobial Resistance: Antimicrobial Resistance Why Some Bacteria Are Hard To Treat 29Antimicrobial Resistance: Antimicrobial Resistance Intrinsic resistance Acquired resistance Mutation Genetic exchange Acquisition of new DNA 30Susceptibility Testing: Susceptibility Testing Determine if microorganism is susceptible to drug Guides therapy 31Susceptibility Testing: Susceptibility Testing Minimum Inhibitory Concentration (MIC) Lowest concentration that prevents visible growth Broth dilution NCCLS 'breakpoints' used to categorize MIC Susceptible Intermediate Resistant 32Susceptibility Testing: Susceptibility Testing Disc Diffusion (Kirby-Bauer) Antibiotic-impregnated disk is placed on agar plate of growing organism Zone created by antibiotic leaching from the disk into the agar is compared to NCCLS ranges 33Pathogenic Bacteria: Pathogenic Bacteria What Makes Us Sick 34Gram-Positive Bacteria: Gram-Positive Bacteria Marked increase in antibiotic resistance Serious and difficult-to-treat infections 35Staphylococci: Staphylococci Staphylococcus aureus Remarkable amount of disease manifestations MRSA Bacteremia and TSS possible Staphylococcus epidermidis Coagulase-negative staph Staphylococcus saprophyticus 36Staphyloccocus aureus: Staphyloccocus aureus 37Staphylococcus Epidermidis: Staphylococcus Epidermidis 38Staphylococcus Saprophyticus: Staphylococcus Saprophyticus 39Pneumoccoci: Pneumoccoci Streptococcus pneumoniae Forcefully attack human body Cause significant amounts of tissue damage Associated with extensive inflammatory response 40Streptococcus pneumoniae: Streptococcus pneumoniae 41Enterococci: Enterococci 'Fickle' residents of the human GI tract Enterococcus faecalis Enterococcus faecium 42Enterococci: Enterococci 43Gram-Negative Bacteria: Gram-Negative Bacteria Most common cause of infection in humans Enterobacteriaceae Large family of bacteria responsible for GI, urinary and opportunistic infections Enteric gram-negative rods 44Enterobacteriaceae: Enterobacteriaceae Escherichia coli Klebsiella spp Proteus spp Enterobacter spp Serratia spp Citrobacter spp Providenicia spp Morganella spp Salmonella enterica Shigella spp Yersinia spp 45Enterobacteriaceae: Enterobacteriaceae 46Pseudomonas: Pseudomonas Pseudomonas aeruginosa Frequent cause of hospital-acquired infections Harbors an array of resistance mechanisms 47Pseudomonas Aeruginosa: Pseudomonas Aeruginosa 48Neisseria: Neisseria Neisseria meningitidis Meningitis Bacteremia possible Neisseria gonorrhoeae Genital gonorrhea 49Anaerobic Bacteria: Anaerobic Bacteria Bacteria unable to grow in the presence of physiologic concentrations of oxygen Mucosal surfaces 50Clostridia: Clostridia Gram-positive spore-forming anaerobic bacteria Clostridium difficile Clostridium tetani 51Clostridia spp: Clostridia spp 52Questions???: Questions??? 53Clostridia spp: Clostridia spp 52Questions???: Questions??? 53